Director, Key Opinion Leader Marketing, Rare Disease

## Director, Key Opinion Leader Marketing, Rare Disease Apply locations:
Cambridge (US) time type:
Full time posted on:
Posted Todayjob requisition :
R-22132
*
* Title:

** Director, Key Opinion Leader Marketing, Rare Disease
** Company:
** Ipsen Biopharmaceuticals Inc.
** About Ipsen:
** Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas:
Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation. Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries.

We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!

For more information, visit us at
**** and follow our latest news on
** Linked In
* * and
** Instagram**.
*
* Job Description:

** Ipsen’s Rare Disease franchise has been expanding through both organic growth and acquisitions. From a marketing standpoint, there is a critical need for excellence in strategic planning and excellence in execution to clearly define how we will best drive education of appropriate healthcare providers, deliver successful launches, and innovate for patients in complex and competitive therapeutic areas.

The Director, Key Opinion Leader Marketing, Rare Disease is a strategic leader within the U.S. Rare Liver Marketing team, responsible for defining and advancing the peer-to-peer engagement strategy across the portfolio. This role serves as the architect of Ipsen's external expert engagement ecosystem, shaping how scientific leaders, advocates, and peer influencers are engaged to advance disease-state education, support earlier diagnosis, inform brand strategy, and drive adoption across existing and future portfolio assets.

This role requires deep expertise in external expert engagement, peer-to-peer education, and congress strategy, as well as the scientific acumen, executive presence, and cross-functional leadership necessary to influence senior stakeholders and drive portfolio-wide impact.

This role owns the strategic direction and governance of speaker bureau excellence, KOL engagement, peer to peer education, and congress activation across the U.S. rare disease portfolio. This individual ensures a coordinated and highly credible external engagement approach that elevates Ipsen's scientific leadership and commercial impact.
** WHAT - Main Responsibilities
**** Peer Engagement Strategy
*** Own and evolve the enterprise peer-to-peer engagement strategy across the U.S. Rare Disease portfolio, ensuring alignment with portfolio growth objectives, competitive dynamics, and future launch priorities
* Establish portfolio-level KOL, speaker, and advocate engagement frameworks, segmentation approaches, and investment priorities that maximize scientific influence and educational impact
* Build a credible, science-driven peer to peer offering aligned to portfolio priorities including tools and resources for TLL team
* Prioritize peer-to-peer programs and channels to expand reach and frequency across key stakeholders
* Build and manage congress roadmap, capabilities, and continually improve associated processes
* Ensure a single, cohesive peer to peer experience aligned to brand strategy and priorities
* Shape how peer influence is leveraged across the customer journey to support disease-state awareness, diagnosis acceleration, treatment adoption, and launch readiness
** Portfolio Leadership & Governance
*** Own and continuously evolve the portfolio speaker bureau strategy, governance, and operating model, ensuring alignment to business priorities and maximizing the impact of peer-to-peer engagement investments
* Establish governance and oversight for speaker engagement, contracting, fair market value rates,…